Associations of a Polymorphism of the FAS/APO-1 Gene (rs2234767) with the Risk of Developing and Rapid Progression of Multiple Sclerosis.

Autor: Nochevnaya, O. M., Pereverzeva, O. V., Sokolova, E. A., Fillipenko, M. L., Zamyatina, S. V., Palashchenko, A. S., Zhdanova, E. S., El’chaninova, S. A., Smagina, I. V.

Publikováno v: Neuroscience & Behavioral Physiology; Jun2018, Vol. 48 Issue 5, p657-660, 4p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The first results of a combined all-Russian study on clinical genetics of multiple sclerosis

Autor: Sokolova, E. A., Malkova, N. A., Korobko, D. S., Rozhdestvensky, A. S., Kakulya, A. V., Khanokh, E. V., Delov, R. A., Platonov, F. A., Popova, T. E., Aref Eva, E. G., Zagorskaya, N. N., Alifirova, V. M., Titova, M. A., Smagina, I. V., Elchaninova, S. A., Popovtseva, A. V., Lichenko, Y. N., Dymova, M. A., Vainer, A. S., P Yankova, O. V., Oskorbin, I. P., Kechin, A. A., Puzyryov, V. P., Kulakova, O. G., Tsareva, E. Y., Olga Favorova, Shchur, S. G., Lashch, N. Y., Popova, N. F., Popova, E. V., Gusev, E. I., Boyko, A. N., Aulchenko, Y. S., Filipenko, M. L.

Publikováno v: Scopus-Elsevier
ResearcherID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2ec664670541a489e358fd0bf10e653e
http://www.scopus.com/inward/record.url?eid=2-s2.0-84940325174&partnerID=MN8TOARS

[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

Autor: Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies, Moscow, Russia., Alifirova VM; Siberian State Medical University, Tomsk, Russia., Lukashevich IG; City Clinical Hospital No. 1, Chelyabinsk, Russia., Goncharova ZA; Rostov State Medical University, Rostov-on-Don, Russia., Greshnova IV; Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russia., Zaslavsky LG; Leningrad Regional Clinical Hospital, St. Petersburg, Russia., Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Malkova NA; State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia., Mishin GN; Pyatigorsk City Clinical Hospital No. 2, Pyatigorsk, Russia., Parshina EV; Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia., Poverennova IY; Seredavin Samara Regional Clinical Hospital, Samara, Russia., Prakhova LN; N. Bechtereva Institute of the Human Brain, St. Petersburg, Russia., Sivertseva SA; Medical and Sanitary unit «Neftyanik», Tyumen, Russia., Smagina IV; Regional Clinical Hospital, Barnaul, Russia., Totolyan NA; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Trinitatsky YV; Rostov Regional Clinical Hospital, Rostov-on-Don, Russia., Trushnikova TN; Wagner Perm State Medical University, Perm, Russia., Khabirov FA; Republican Clinical Nerological Center, Kazan, Russia., Chefranova JY; Belgorod Regional Clinical Hospital of St. Joasaph, Belgorod, Russia., Shchur SG; Municipal Filatov Clinical Hospital No. 15, Moscow, Russia., Dudin VA; Center for Cardiology and Neurology, Kirov, Russia., Pokhabov DV; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Artemeva AV; JSC BIOCAD, St. Petersburg, Russia., Eremeeva AV; JSC BIOCAD, St. Petersburg, Russia., Linkova YN; JSC BIOCAD, St. Petersburg, Russia., Zinkina-Orikhan AV; JSC BIOCAD, St. Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2024; Vol. 124 (4), pp. 86-96.

[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].

Autor: Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies, Moscow, Russia., Alifirova VM; Siberian State Medical University, Tomsk, Russia., Lukashevich IG; Orden of the Red Banner of Labor City Clinical Hospital No. 1, Chelyabinsk, Russia., Goncharova ZA; Rostov State Medical University, Rostov-on-Don, Russia., Greshnova IV; Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russia., Zaslavsky LG; Leningrad Regional Clinical Hospital, St. Petersburg, Russia., Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Malkova NA; State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia., Mishin GN; Pyatigorsk City Clinical Hospital No. 2, Pyatigorsk, Russia., Parshina EV; Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia., Poverennova IY; Seredavin Samara Regional Clinical Hospital, Samara, Russia., Prakhova LN; N. Bechtereva Institute of the Human Brain, St. Petersburg, Russia., Sivertseva SA; Medical and Sanitary unit «Neftyanik», Tyumen, Russia., Smagina IV; Regional Clinical Hospital, Barnaul, Russia., Totolyan NA; Academician I.P. Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Trinitatsky YV; Rostov Regional Clinical Hospital, Rostov-on-Don, Russia., Trushnikova TN; Wagner Perm State Medical University, Perm, Russia., Khabirov FA; Republican Clinical Nerological Center, Kazan, Russia., Shchur SG; Municipal Filatov Clinical Hospital No. 15, Moscow, Russia., Artemyeva AV; AO BIOCAD, St. Petersburg, Russia., Bolsun DD; AO BIOCAD, St. Petersburg, Russia., Zinkina-Orikhan AV; AO BIOCAD, St. Petersburg, Russia., Linkova YN; AO BIOCAD, St. Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (4), pp. 37-47.